Usman Malik
at Getz Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Getz Pharma
-
Pakistan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
-
Apr 2023 - Present
Leading sales and marketing teamHeart Failure, Hypertension and Diabetes
-
-
-
Jan 2022 - Apr 2023
Launched Diampa LT (Empagliflozin/Linagliptin) which was pharma industry best launch and achieved 40% MS in its category on IQVIA MAT ~ 03/2023 (value) Diabetes, Dyslipidemia and Hypertension portfolio
-
-
-
Jan 2021 - Jan 2022
Diabetes, Dyslipidemia and Hypertension portfolio
-
-
-
Jul 2019 - Jan 2021
Launched Savesto (Sacubitril/Valsartan)and achieved 56.7% MS on MAT ~ 01/2021 (units)Diabetes, Dyslipidemia, Hypertension and Heart Failure portfolio
-
-
-
Novo Nordisk
-
Denmark
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Product Manager
-
Jan 2018 - Jun 2019
Responsible for modern insulin brands, NovoMix 30 and 50. Crossed Humalog 30 and 50 in market share through robust marketing support Responsible for modern insulin brands, NovoMix 30 and 50. Crossed Humalog 30 and 50 in market share through robust marketing support
-
-
-
Getz Pharma
-
Pakistan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Product Manager
-
May 2017 - Jan 2018
Cardio-metabolic portfolio Cardio-metabolic portfolio
-
-
-
Highnoon Laboratories Ltd
-
Pharmaceutical Manufacturing
-
300 - 400 Employee
-
Senior Product Manager
-
Dec 2015 - Apr 2017
Respiratory portfolio, which includes dry powder inhalers Respiratory portfolio, which includes dry powder inhalers
-
-
-
CCL Pharmaceuticals
-
Pakistan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
-
Aug 2014 - Dec 2015
-
-
-
Feb 2013 - Aug 2014
-
-
-
-
Manager Operations
-
Feb 2012 - Oct 2012
-
-
-
-
Professional Sales Representative
-
Feb 2010 - Jan 2011
-
-
Education
-
Coventry University
Master of Business Administration (MBA), Marketing -
Baqai Medical University
Doctor of Pharmacy (Pharm.D.)